Breast Adenocarcinoma — Trials

Breast Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,711 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 685
Recruiting: 381
Ph III recruiting: 44
Growth YoY: +8.6%
Industry share: 24%
Top sponsor: Fudan University
Termination share: 44.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (277)

clinicaltrialsPublishedShowing 1–16 of 16 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07768358	Tucatinib Continuation Study	not yet recruiting	Phase 4	175	PfizerINDUSTRY	0	Aug 28, 2026	clinicaltrials
NCT05183828	Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer	terminated	Phase 4	62	University of WashingtonOTHER	1	Jun 4, 2026	clinicaltrials
NCT07589699